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Problem Identification
• While approximately 30,000 cases of 
Lyme disease are reported to the CDC 
annually, the CDC estimates 
approximately 300,000 individuals in the 
US become infected
• Incidence of Lyme disease has risen 
significantly in the past decade
• Vermont has the second-highest 3-year 
incidence rate of Lyme disease in the 
United States
• Treatment  with extended courses of 
antibiotics for nonspecific symptoms of 
post-treatment Lyme disease syndrome 
has increased from 29.9% in 2004-2006 
to 49.9% in 2010-2012
• A small group of providers (roughly 3%-
4%) were responsible for >20% of the 
patients who were prescribed extended 
antibiotic treatment for post-treatment 
Lyme disease syndrome
• Over 5 randomized controlled trails have not 
demonstrated any benefit in prolonged 
antibiotic therapy for Lyme disease even in 
patients with persistent symptoms 
Public Health Cost
• A 2014 study estimated the cost of testing alone to be approximately 
$492 million annually in the US
• A 2015 report estimates of the average cost of Lyme disease to be 
~$3,000 per patient over the course of the disease costing the US 
healthcare system approximately $1 billion per year ($712m – $1.3b)
• Post-Treatment Lyme Disease Syndrome costs the healthcare system an 
additional $3798 per case
• Prolonged antibiotic courses and associated healthcare visits in the year 
following a Lyme disease diagnosis cost the healthcare system an 
additional $1 billion annually 
Community Perspective 
• Observed obstacles to prevention & diagnosis 
• Misunderstanding of when and how to perform tick checks
• Public knowledge of preventing tick bites (ie. appropriate dress, repellant)
• Public misunderstanding of tick bite timing and disease transmission
• Patient knowledge of symptoms of Lyme disease (what to look for, when 
to call)
• Obstacles to appropriate management of Lyme disease 
• Lyme disease misrepresentation in the media 
• Vtlyme.org compiled over 40 instances of media sources in VT publishing misinformation about tick bites and 
the Erythema Migrans rash from 2017-2019
• Misinformation and mismanagement of Post-treatment Lyme Disease Syndrome
• “Lyme literate” providers treat patients with non-specific symptoms with extended courses of antibiotics 
despite repeated randomized controlled clinical trials indicating that this treatment course has no benefit and 
can lead to complications related to prolonged antibiotic use such as opportunistic infections
Community Perspective 
• On detection & prevention of Lyme disease 
“People are not aware of the wide range of symptoms of tickborne illnesses, and that weeks, 
months or years can pass between a tick bite and symptom onset.”
• – Rebecca Zelis, founder & content creator of VTLyme.org
• On  obstacles to appropriate management of Lyme disease 
“Particularly in children, the diagnosis of the vast majority of Lyme disease cases, with 
appropriate consultation with an expert if needed, can often be fairly straightforward. But 
there is no shortage of irresponsible practitioners of all stripes who are willing to make 
diagnoses and offer treatments completely outside the boundaries of accepted medical 
practice, for those who are motivated to seek them out.” 
• – Dr. Benjamin Lee, pediatric infectious disease specialist, UVMMC
Intervention and Methodology
Generation of a pamphlet/education handout with information on:  
• Techniques for Lyme disease prevention and detection 
• When and where to use protection against 
• How to effectively check yourself and others for ticks
• How to identify different types of ticks
• How to properly remove a tick
• When to call your doctor or be seen for a tick bite
• Symptoms to look out for
• Appearance of rash that can appear with Lyme disease
• Evidence-based information about treatment 
• Common misconceptions about Lyme disease treatment that result in inappropriate use of prolonged antibiotic courses to treat persistent and non-specific symptoms 
attributed to Lyme disease 
• Risks of prolonged antibiotic use especially when there is no evidence of symptom improvement
• Credible sources on Lyme disease prevention, diagnosis, and treatment 
• Provide information about accessing the CDC website and Vtlyme.org 
• Emphasis on the frequent misrepresentation of Lyme disease in the media 
• Cautioning against following recommendations made by the media 
Methodology 
• Information for the aforementioned pamphlet was accumulated from a literature review of databases including PubMed, the CDC, interviews with infectious disease 
specialists and community members, as well as programs aimed at community education including VTLyme.org
• Distribution of the pamphlet to be available to patients and visitors of Colchester Family Practice and handed out to patients that may be at higher risk
Response
Effectiveness and Limitations
• The effectiveness of this intervention cannot be specifically measured at this time but 
is one of many efforts to increase awareness and methods of presentation and 
diagnosis of Lyme disease
• Goal of long-term reduction in rates of Lyme disease in the community would be 
difficult to attribute to any one of many preventative initiatives
• However, surveying patients and visitors to Colchester Family Practice as well as groups in the 
community such as schools, day cares, and summer camps on their basic knowledge of Lyme 
disease and proper prevention could be influential
• Limitations include: 
• Limited size of the patient population at Colchester Family Practice
• Distributing information in a medical setting is less likely to reach those most susceptible to Lyme 
disease misinformation 
• Distribution of this pamphlet would be more beneficial in neutral settings such as community centers and 
summer camps 
• Lack of a method to assess whether the pamphlet has improved community understanding of 
Lyme disease 
Recommendations
• Awareness of the common misconceptions and basics of Lyme disease is 
still an ongoing issue and more can be done to increase the 
understanding in our community 
• Further distribution of this pamphlet in neutral environments such as 
community centers and camps 
• Include Lyme disease reading in the After Visit Summary of patients, 
especially families with children and during months of high incidence
• Proactively ask patients and families thought to be at higher risk what 
they know about ticks and Lyme disease during annual visits
• Generate a survey for patients and visitors asking basic of Lyme disease 
in order to more closely understand where there are gaps in knowledge
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